Avelos Therapeutics develops next-generation targeted oncology medicines with high unmet need, to a wider range of possibilities with present and future applications, especially in the areas of cell cycle regulation, undruggable cancer targets, and DNA damage response with a primary focus on synthetic lethality.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 3f, 21 Magokjungang 8-Ro 7-Gil, Gangseo-Gu, Seoul,07794,korea, Republic Of
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.avelostx.com
- Keywords
- Aimed Bio Inc..
- HQ
- Seoul
Avelos Therapeutics Questions
Avelos Therapeutics's website is http://www.avelostx.com
Avelos Therapeutics's LinkedIn profile is https://kr.linkedin.com/company/avelostx
Avelos Therapeutics has
9 employees.
View email and phone details for 9
employees at Avelos Therapeutics.
Avelos Therapeutics's industry is
Biotechnology Research
Avelos Therapeutics's top competitors are
Txinno Bioscience Inc,
Hogwarts Ltd.,
Ninetap,
Myriad Partners,
Fashionxdao,
Aimed Bio Inc.,
J.d. Pools,
Synaptic,
Biobook,
Insilico Medicine.
Avelos Therapeutics's categories are Biotechnology Research
Avelos Therapeutics's founding year is 2021
